Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,749.8 | 132.71 | 4,18,084.12 | 1,181.05 | 0.77 | 5,985.33 | 98.33 |
Divis Laboratories Ltd DIVISLAB | 6,140.55 | 78.33 | 1,62,384.48 | 594 | 0.49 | 2,297 | 513.62 |
Cipla Ltd CIPLA | 1,472.25 | 25.54 | 1,18,852.52 | 1,438.15 | 0.88 | 4,134.87 | 360.73 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,258.6 | 58.65 | 1,06,989.64 | 485 | 0.89 | 2,330 | 222.38 |
Dr Reddys Laboratories Ltd DRREDDY | 1,240.4 | 19.9 | 1,03,143.15 | 849.4 | 0.65 | 4,997.8 | 322.47 |
The IPO that was opened between December 11 and December 13, 2024 aggregates to ₹3,042.62 crore and has had a price band of ₹533-549 per equity share.
Investors can bid for up to 27 shares in a single lot, with the company setting a price range of Rs 522-549 per share.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.